FDA approves quizartinib for newly diagnosed acute myeloid leukemia

FDA approves quizartinib for newly diagnosed acute myeloid leukemia

Source: FDA Center for Drug Evaluation and Research - What's New - July 20, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news